Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 69959

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
December 05, 2014
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
Eisai Inc

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

BELVIQ¿ (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960.

D-0302-2015
Recall number
D-0302-2015
Initiated
December 05, 2014
Classification
Class III
Status
Terminated
Recalling firm
Eisai Inc
Quantity
121,680 bottles

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling:Missing

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.

Code information

Lot #13297008, Exp. 11/15;13307008, Exp. 11/15;13367008, Exp.12/15.

Distribution pattern

Nationwide.